To investigate the role of Calpain in the pathogenesis of CML, we first determined the mechanism for increased expression of the calpain inhibitor Gas2 in Bcr-abl expressing cells. Here, GAS2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.